Imagine a world where doctors are able to target and remove infected cells, pathogens, toxins, or even viruses directly from a patient's bloodstream. At MediSieve we are working towards bringing this dream into a reality. Our Magnetic Blood Filtration System is a device-therapeutic combination that filters harmful substances from the bloodstream using magnetic forces.

If you've always dreamt of making a global impact, MediSieve is the place to be! The platform nature of our technology enables us to make a difference in treating humanity's most serious diseases, with the first product targeting hyperinflammation in conditions such as COVID-19, Sepsis, and Cytokine Release Syndrome.

Join Our Team As

Latest News

MediSieve raises additional £1.8 million in funding

MediSieve raises additional £1.8 million in funding
June 24, 2021

MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, today announced a £1.8m investment, led by 24Haymarket. This investment will fund first-inman trials investigating the safety and efficacy of the company’s pivotal IL-6 product. MediSieve has developed ...
MediSieve selected for the London & Partners’ Business Growth Programme

MediSieve selected for the London & Partners’ Business Growth Programme
June 05, 2020

MediSieve was accepted onto the London & Partners’ Business Growth Programme! The free, three-month programme is giving London-based companies the tools they need to survive and thrive during these challenging times - from mentorship and account management, to expert advice and new business opportu...